NCT04439357

Clinical Trial Information


Trial Number: NCT04439357 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol S2: Phase II Study of Trametinib in Patients With Tumors With GNAQ or GNA11 Mutations
Study ID:
EAY131-S2
Images are available?:
No
Is this a NCI-MATCH Trial?:
No